← Back to Clinical Trials
Recruiting NCT07797296

NCT07797296 Predictors of Religious Orientation Attitudes in Menopausal Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07797296
Status Recruiting
Phase
Sponsor KTO Karatay University
Condition Menopause
Study Type OBSERVATIONAL
Enrollment 97 participants
Start Date 2026-08-26
Primary Completion 2027-02-01

Eligibility & Interventions

Sex Female only
Min Age 49 Years
Max Age 59 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 97 participants in total. It began in 2026-08-26 with a primary completion date of 2027-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This descriptive, cross-sectional study examines whether the severity of menopausal symptoms and attitudes toward sexual myths predict intrinsic religious orientation in menopausal women. Menopause is a multidimensional transition with biological, psychological, social and spiritual aspects, and in societies with a strong cultural and religious fabric women may draw on religious orientation as a coping and meaning-making resource. Participants are healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease, recruited in Konya, Turkey. Data are collected face to face using a personal information form, the Menopause Rating Scale, the Intrinsic Religious Orientation Scale and the Sexual Myths Scale, and analysed with multiple regression.

Eligibility Criteria

Inclusion Criteria: * Woman aged 49 to 59 years * Diagnosis of menopause * No chronic health problem * Volunteers to participate and provides written informed consent Exclusion Criteria: \* Presence of a chronic disease (e.g. cardiac disease, diabetes, hypertension)

Contact & Investigator

Central Contact

Hasan Gercek, PhD

✉ hasan.gercek@acibadem.edu.tr

📞 +90 542 648 8455

Principal Investigator

Aslihan Turan

PRINCIPAL INVESTIGATOR

KTO Karatay University

Frequently Asked Questions

Who can join the NCT07797296 clinical trial?

This trial is open to female participants only, aged 49 Years or older, up to 59 Years, studying Menopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07797296 currently recruiting?

Yes, NCT07797296 is actively recruiting participants. Contact the research team at hasan.gercek@acibadem.edu.tr for enrollment information.

Where is the NCT07797296 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT07797296 clinical trial?

NCT07797296 is sponsored by KTO Karatay University. The principal investigator is Aslihan Turan at KTO Karatay University. The trial plans to enroll 97 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology